The FDA’s Social-Media Guidelines for the Pharmaceutical Industry-2014
Introductions
The U.S. Food and Drug Administration suggested few recommendations on role of social media in pharmaceutical industry. Nowadays, social media offering a flexible ways to health care providers for collaborating with consumers in different domains who involved in healthcare like accountable care, personalized medicine, shared decision making, to emerging trends in diagnoses, treatments and models of care management.
FDA observes constantly to its regulatory promotions and marketing, at the same time, must ensure patient safety and creating timely regulations and/or recommendations to the newly upcoming coming social software tools.
Pharma’s Opportunities in Social Media
Now consumers easily share their opinion about products and brands through unique technologies and media. Consumers expect a proper response from companies to address their needs, answer questions and solutions to complaints. There is a major challenge to companies how to use social media not only for traditional marketing models and also improve programs and find opportunities where this social media can develops benefits of those strategies to consumers and health care providers.
FDA suggested few recommendations that save industries from misinformation raised by social media guidelines.
Fda, social media, health care, pharma industry